Miglustat for treatment of Niemann-Pick C disease: a randomised
Por um escritor misterioso
Descrição
Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice
Niemann-Pick Disease, Type a disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
Frontiers Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases
Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases
PDF] Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Cost-effectiveness of miglustat versus symptomatic therapy of Niemann–Pick disease type C
Prevalence of dysphagia in Niemann-Pick disease type C (NP-C) and other
IJMS, Free Full-Text
Diagnostic workup and management of patients with suspected Niemann-Pick type C disease - Apostolos Papandreou, Paul Gissen, 2016
PDF] Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts
Frontiers Adult-Onset Niemann–Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult
Miglustat in patients with Niemann-Pick disease Type C (NP-C): A
de
por adulto (o preço varia de acordo com o tamanho do grupo)